Studies on the mechanism of action of inhibitors of the fibrinolysin system.
D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D007611:Aprotinin / Q000494:pharmacology; D001120:Arginine / Q000494:pharmacology; D001774:Blood Chemical Analysis; D001777:Blood Coagulation / Q000187:drug effects; D002364:Caseins / Q000037:antagonists & inhibitors; D002417:Cattle; D003509:Cyclohexanecarboxylic Acids / Q000494:pharmacology; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000037:antagonists & inhibitors*; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D007456:Iodine Isotopes; D010447:Peptide Hydrolases / Q000494:pharmacology; D010958:Plasminogen / Q000037:antagonists & inhibitors; D013300:Streptokinase / Q000494:pharmacology; D013917:Thrombin / Q000032:analysis; D014508:Urea
D000614:Aminocaproates; D000933:Antifibrinolytic Agents; D002364:Caseins; D003509:Cyclohexanecarboxylic Acids; D005343:Fibrinolytic Agents; D007456:Iodine Isotopes; D014508:Urea; D005340:Fibrinogen; D010958:Plasminogen; D007611:Aprotinin; D001120:Arginine; D010447:Peptide Hydrolases; D013300:Streptokinase; D013917:Thrombin; D005341:Fibrinolysin